SCHEMBL23977642

SCHEMBL23977642

Fc1cc2[nH]ncc2cc1Cl

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 5/20 0.50
DYRK1A Q13627 2/20 0.50
CHEK1 O14757 1/20 0.48
MAOB P27338 5/20 0.48
TRPA1 O75762 4/20 0.46
TRPM8 Q7Z2W7 1/20 0.45
TRPV1 Q8NER1 1/20 0.45
FGFR1 P11362 1/20 0.44
FGFR2 P21802 1/20 0.44
MAPT P10636 2/20 0.43
ALDH1A1 P00352 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
METAP2 P50579 3/20 0.42
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
PKM P14618 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
CSNK2A1 P68400 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14312467 0.92 NOS1 (0.50) NOS1DYRK1ACHEK1MAOBTRPA1
SCHEMBL14738406 0.83 CHEK1 (0.56) NOS1DYRK1ACHEK1MAOBTRPA1
SCHEMBL3590783 0.83 NOS1 (0.57) NOS1DYRK1ACHEK1MAOBTRPA1
SCHEMBL13692758 0.78 NOS1 (0.52) NOS1DYRK1ACHEK1TRPA1FGFR1
SCHEMBL9917347 0.78 NOS1 (0.52) NOS1DYRK1ACHEK1TRPA1TRPM8
SCHEMBL15288335 0.76 AXL (0.51) NOS1DYRK1ACHEK1MAOBTRPA1
SCHEMBL12435218 0.76 CHEK1 (0.48) NOS1DYRK1ACHEK1TRPA1TRPM8
SCHEMBL18345083 0.76 FGFR1 (0.60) NOS1DYRK1ACHEK1TRPA1FGFR1
SCHEMBL828690 0.76 AXL (0.56) NOS1DYRK1ACHEK1TRPA1FGFR1
SCHEMBL23219864 0.76 NOS1 (0.50) NOS1DYRK1ACHEK1MAOBTRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250197406-A1 INDAZOLES AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) INHIBITORS AND METHODS FOR USING SAME 1ST Biotherapeutics, Inc. (KR) 2025-06-19 US disclosed
US-11649255-B2 Indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors and methods using same 1ST Biotherapeutics, Inc. (KR) 2023-05-16 US disclosed
WO-2023061294-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 再鼎医药(上海)有限公司 2023-04-20 WO disclosed
CN-114599651-A Indazoles as inhibitors of hematopoietic progenitor kinase 1(HPK1) and methods of use thereof 第一生物治疗股份有限公司 2022-06-07 CN disclosed
US-20220098193-A1 INDAZOLES AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) INHIBITORS AND METHODS USING SAME 1ST Biotherapeutics, Inc. 2022-03-31 US disclosed
WO-2021219091-A2 QUINOXALINONE DERIVATIVE AS IRREVERSIBLE INHIBITOR OF KRAS G12C MUTANT PROTEIN 北京泰德制药股份有限公司 (CN) 2021-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11649255-B2 Indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors and methods using same IP6K1, HIPK1, IP6K3 NOS1 2864/4885DYRK1A 595/4885CHEK1 179/4885
US-20220098193-A1 INDAZOLES AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) INHIBITORS AND METHODS USING SAME IP6K1, HIPK1, IP6K3 NOS1 2864/4885DYRK1A 595/4885CHEK1 179/4885
US-20250197406-A1 INDAZOLES AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) INHIBITORS AND METHODS FOR USING SAME IP6K1, HIPK1, IP6K3 NOS1 2589/4885DYRK1A 626/4885CHEK1 217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.